期刊文献+

终末期肝病模型评估我国肝硬化患者预后的能力 被引量:5

Capability of end-stage liver disease model in predicting the prognosis of Chinese patients with liver cirrhosis
下载PDF
导出
摘要 目的:评价终末期肝病模型(MELD)在评估我国肝硬化患者预后方面的作用.方法:选择具有完整临床资料和随访结果的216例肝硬化患者进行回顾性分析.利用受试者工作特征曲线(ROC)及其下面积(AUC)比较MELD、美国器官共享网络(UNOS)修改后的MELD(U-MELDl、Child-Turcotte- Pugh(CTP)评分及分级判断预后的能力.每位患者的MELD值根据Kamath修改后的公式计算,U-MELD值根据UNOS修改后的计算方法计算.AUC的比较采用非参数方法.结果:MELD在判断患者3,6 mo,1a等生存时间的ROC曲线AUC值分别是0.838.0.856.0.877,均大于CTP评分及分级的AUC值.与CTP分级有显著性差异,但与CTP评分无显著性差异.U-MELD在判断3mo预后时的AUC值与CTP评分的差异有统计学意义(P=0.028),而在6mo,1a时两者间的AUC差异尚无统计学意义.结论:MELD与CTP评分的差异无统计学意义,而U-MELD在评估3mo预后方面较CTP评分已有显著优势. AIM: To evaluate the capability of the model for end-stage liver disease (MELD) in predicting the prognosis of Chinese patients with liver cirrhosis. METHODS: A cohort of 216 patients with liver cirrhosis were retrospectively studied and followed up. The area under the receiver operating characteristic (ROC) curve (AUC) was used to compare MELD, U-MELD (MELD modified by the United Network for Organ Sharing), Child- Turcotte-Pugh (CTP) score and classification in predicting accuracy. MELD score was obtained for each patient according to the modified formula by Kamath. U-MELD score was obtained according to the modified formula by the United Network for Organ Sharing (UNOS). Nonparametric approach was applied for the comparison of AUC. RESULTS: The AUC value generated by the ROC curve for MELD was 0.838 at 3 mo, 0.856 at 6 mo and 0.877 at 1 year. MELD was better than CTP classification, and there was significant difference between them. However, there was no significant difference between MELD and CTP score. U-MELD was more accurate than CTP score in predicting the 3-mo prognosis (P = 0.028), while it did not show significant superiority in predicting 6-mo and 1-year prognosis. CONCLUSION: There is no significant difference between MELD and CTP score, but U-MELD is superior to CTP score in predicting the 3-mo prognosis.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第29期2889-2892,共4页 World Chinese Journal of Digestology
关键词 肝硬化 预后 模型 Liver cirrhosis Prognosis Model
  • 相关文献

参考文献14

  • 1Malinchoc M,Kamath PS,Gordon FD,Peine CJ,Rank J,ter Borg PC.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatology 2000;31:864-871
  • 2Kamath PS,Wiesner RH,Malinchoc M,Kremers W,Therneau TM,Kosberg CL,D'Amico G,Dickson ER,Kim WR.A model to predict survival in patients with end-stage liver disease.Hepatology 2001; 33:464-470
  • 3Wiesner R,Edwards E,Freeman R,Harper A,Kim R,Kamath P,Kremers W,Lake J,Howard T,Merion RM,Wolfe RA,Krom R.Model for end-stage liver disease (MELD) and allocation of donor livers.Gastroenterology 2003; 124:91-96
  • 4Srikureja W,Kyulo NL,Runyon BA,Hu KQ.MELD score is a better prognostic model than ChildTurcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.J Hepatol 2005;42:700-706
  • 5Angermayr B,Cejna M,Karnel F,Gschwantler M,Koenig F,Pidlich J,Mendel H,Pichler L,Wichlas M,Kreil A,Schmid M,Ferlitsch A,Lipinski E,Brunner H,Lammer J,Ferenci P,Gangl A,Peck-Radosavljevic M.Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.Gut 2003; 52:879-885
  • 6Pugh RN,Murray-Lyon IM,Dawson JL,Pietroni MC,Williams R.Transection of the oesophagus for bleeding oesophageal varices.Br J Surg 1973; 60:646-649
  • 7DeLong ER,DeLong DM,Clarke-Pearson DL.Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach.Biometrics 1988; 44:837-845
  • 8Harley JA,McNeil BJ.The meaning and use of the area under a receiver operating characteristic (ROC)curve.Radiology 1982; 143:29-36
  • 9Chalasani N,Kahi C,Francois F,Pinto A,Marathe A,Bini EJ,Pandya P,Sitaraman S,Shen J.Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding.Hepatology 2002; 35:1282-1284
  • 10Giannini E,Botta F,Testa E,Romagnoli P,Polegato S,Malfatti F,Fumagalli A,Chiarbonello B,Risso D,Testa R.The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.Am J Gastroenterol 2002; 97:2855-2860

同被引文献36

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部